Selective biologics for ulcerative colitis and Crohn's disease – clinical utility of vedolizumab
Jill MV Petkau, Bertus Eksteen Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada Abstract: Inflammatory bowel disease (IBD) encompasses a cluster of different disease phenotypes which are broadly classified into ulcerative colitis and Croh...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-03-01
|
| Series: | Biologics : Targets & Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/selective-biologics-for-ulcerative-colitis-and-crohn39s-disease-ndash--peer-reviewed-article-BTT |